Article
The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins.
Cancer research - 15 Jun 2006
Iervolino Angela, Iuliano Rodolfo, Trapasso Francesco, Viglietto Giuseppe, Melillo Rosa Marina, Carlomagno Francesca, Santoro Massimo, Fusco Alfredo
Abstract excerpt
Thyroid cancer is frequently associated with the oncogenic conversion of the RET receptor tyrosine kinase. RET gene rearrangements, which lead to the generation of chimeric RET/papillary thyroid carcinoma (PTC) oncogenes, occur in PTC, whereas RET point mutations occur in familial multiple endocrine neoplasia type 2 (MEN2) and sporadic medullary thyroid carcinomas (MTC). We showed previously that the expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
